QumulusAI files for direct listing on Nasdaq

QumulusAI filed for a proposed direct listing on the Nasdaq Global Market, according to a registration statement filed today. The company plans to list under the ticker symbol "QMLS."

The filing registers the resale of all currently issued and outstanding common stock by existing shareholders. Shares held by directors, officers, and shareholders owning more than 10% of the company will be restricted from trading for six months following the listing.

Between January 1, 2025, and December 1, 2025, QumulusAI issued shares to investors at prices ranging from $1.00 to $3.60 per share. The company noted these historical prices may not reflect broader market demand once trading begins.

Unlike a traditional initial public offering, the direct listing will not be underwritten by investment banks. Existing shareholders may choose to sell their shares through brokerage transactions at prevailing market prices. QumulusAI will not receive proceeds from any share sales.

Chardan Capital Markets LLC serves as the company's financial advisor for the listing process. Chardan will determine when shares are ready to trade and approve proceeding at Nasdaq's Current Reference Price, which is calculated based on pre-opening buy and sell orders.

No public market currently exists for QumulusAI's common stock. The company warned that trading volume and share price volatility may be higher than in a traditional underwritten offering due to the novel nature of direct listings.

The registration statement did not specify the total number of shares being registered for resale.

You May Also Be Interested In